Nanobiotix S.A. (0QAV.L)

EUR 3.48

(1.75%)

Revenue Summary of Nanobiotix S.A.

Nanobiotix S.A.'s latest annual revenue in 2023 was 30.05 Million EUR , up 658.12% from previous year.
Nanobiotix S.A.'s latest quarterly revenue in 2024 Q2 was 9.28 Million EUR , down 0.0% from previous quarter.
Nanobiotix S.A. reported a annual revenue of 4.77 Million EUR in annual revenue 2022, up 47660.0% from previous year.
Nanobiotix S.A. reported a annual revenue of 10 Thousand EUR in annual revenue 2021, down -80.0% from previous year.
Nanobiotix S.A. reported a quarterly revenue of 3.29 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Nanobiotix S.A. reported a quarterly revenue of 32.91 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Nanobiotix S.A. (2023 - 2012)

Historical Annual Revenue of Nanobiotix S.A. (2023 - 2012)

Year	Revenue	Revenue Growth
2023	30.05 Million EUR	658.12%
2022	4.77 Million EUR	47660.0%
2021	10 Thousand EUR	-80.0%
2020	50 Thousand EUR	-26.47%
2019	68 Thousand EUR	-41.38%
2018	116 Thousand EUR	-53.96%
2017	251.96 Thousand EUR	-83.83%
2016	1.55 Million EUR	486.76%
2015	265.54 Thousand EUR	-90.42%
2014	2.77 Million EUR	73.67%
2013	1.59 Million EUR	64.38%
2012	970.6 Thousand EUR	0.0%

Year	Revenue	Revenue Growth
2024 Q2	9.28 Million EUR	0.0%
2023 Q2	3.29 Million EUR	0.0%
2023 Q4	32.91 Million EUR	0.0%
2023 FY	30.05 Million EUR	529.36%
2022 Q4	3.44 Million EUR	0.0%
2022 FY	4.77 Million EUR	47660.0%
2022 Q2	1.32 Million EUR	0.0%
2021 Q4	1.32 Million EUR	0.0%
2021 Q2	10 Thousand EUR	0.0%
2021 FY	10 Thousand EUR	-80.0%
2020 FY	50 Thousand EUR	-26.47%
2020 Q2	37 Thousand EUR	0.0%
2020 Q4	13 Thousand EUR	0.0%
2019 Q4	31 Thousand EUR	0.0%
2019 Q2	37 Thousand EUR	0.0%
2019 FY	68 Thousand EUR	-41.38%
2018 FY	116 Thousand EUR	-53.96%
2018 Q4	1.41 Million EUR	0.0%
2018 Q2	2.06 Million EUR	0.0%
2017 Q2	1.88 Million EUR	0.0%
2017 FY	251.96 Thousand EUR	-83.83%
2017 Q4	1.83 Million EUR	0.0%
2016 Q2	3.03 Million EUR	0.0%
2016 FY	1.55 Million EUR	486.76%
2016 Q4	2.38 Million EUR	0.0%
2015 FY	265.54 Thousand EUR	-90.42%
2015 Q4	2.35 Million EUR	0.0%
2015 Q2	1.65 Million EUR	0.0%
2014 FY	2.77 Million EUR	73.67%
2014 Q2	997.39 Thousand EUR	0.0%
2014 Q4	1.77 Million EUR	0.0%
2013 Q4	929.01 Thousand EUR	0.0%
2013 Q2	666.45 Thousand EUR	0.0%
2013 FY	1.59 Million EUR	64.38%
2012 Q3	252.24 Thousand EUR	0.0%
2012 FY	970.6 Thousand EUR	0.0%
2012 Q4	252.24 Thousand EUR	0.0%

Peer Revenue Comparison of Nanobiotix S.A.

Name	Revenue	Revenue Difference
Boiron SA	493.24 Million EUR	93.906%
Laboratorios Farmaceuticos Rovi, S.A.	829.5 Million EUR	96.376%
Vetoquinol SA	529.27 Million EUR	94.321%
Valneva SE	153.71 Million EUR	80.445%
AB Science S.A.	970 Thousand EUR	-2998.763%
PHAXIAM Therapeutics S.A.	1.32 Million EUR	-2166.817%
Vivoryon Therapeutics N.V.	-3.62 Million EUR	930.331%
BioSenic S.A.	543 Thousand EUR	-5435.543%
ABIVAX Société Anonyme	4.62 Million EUR	-550.465%
Formycon AG	77.69 Million EUR	61.313%